Abdominal Wall Metastasis of Uterine Papillary Serous Carcinoma in a Post-Menopausal Woman: A Case Report.
- Author:
Jung Woo PARK
1
;
Sung Ook HWANG
Author Information
- Publication Type:Case Report
- Keywords: Abdominal wall; Postmenopause; Uterine papillary serous carcinoma
- MeSH: Abdomen; Abdominal Wall*; Carboplatin; Diagnosis; Drug Therapy; Endometrial Neoplasms; Endometrium; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Metastasis*; Ovum; Paclitaxel; Positron-Emission Tomography; Postmenopause; Prognosis; Recurrence
- From:Journal of Menopausal Medicine 2014;20(1):35-38
- CountryRepublic of Korea
- Language:English
- Abstract: Uterine papillary serous carcinoma (UPSC) is an aggressive form of endometrial cancer characterized by a high recurrence rate and poor prognosis. We report a case of a 58-year-old post-menopausal woman with an abdominal wall metastasis in stage IA UPSC. After surgical staging, she did not receive additional adjuvant therapy. An egg sized palpable mass developed in the right lower abdomen after 8 months. Both Abdominopelvic computed tomography (CT) and positron emission tomography (PET)-CT revealed a metastatic lesion in the abdominal wall. Hence, surgical excision was performed. The pathological findings showed metastatic UPSC with clear resection margin. After the diagnosis of UPSC metastasis in the abdominal wall, she received chemotherapy utilizing paclitaxel and carboplatin. After 3 years, no evidence of recurrence was found. Therefore, we suggest that even when UPSC is confined to the endometrium without lymph node metastasis and without lymphovascular invasion, chemotherapy should be considered as a postoperative adjuvant therapy.
